Search

everythinglearnresearchcommunity

for

Search:↓

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

These medications for BPH have known risks and may have new side effects.

Neurosteroids may help metyrapone reduce cocaine addiction.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Blocking a protein called prostaglandin D2 might help treat hair loss.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Trichotillomania was successfully treated with risperidone and naltrexone.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

The compound 4c effectively inhibits the enzyme linked to hair loss.

N-acetylcysteine and memantine are recommended as safe and effective treatments for trichotillomania.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Doxazosin and finasteride negatively affect sexual function in men with BPH.